Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor Α-Associated Diseases From a Molecular View
Journal of Biological Chemistry - United States
doi 10.1074/jbc.m113.491530
Full Text
Open PDFAbstract
Available in full text
Date
August 13, 2013
Authors
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)